Please upgrade your browser.
A list of abstracts from the 2012 ASCO meeting that mention kidney cancer. Do your own research. Become an empowered patient.
Bayer is testing regorafenib against a number of tumor types including kidney cancer.
Martin Voss, M.D., receives KCA/CCF Young Investigator Award at world's largest oncology meeting in Chicago.
Bristol-Myers Squibb Company (BMY) today announced interim results from the expanded Phase 1 dose-ranging study 003 (n=296) of its investigational anti-PD-1 immunotherapy (BMS-936558), which showed clinical activity in patients with previously-treated non small-cell lung cancer (NSCLC), metastatic melanoma and renal cell carcinoma (RCC).
The gorjana Kidney Cancer Association Necklace has been designed especially for The Kidney Cancer Association. 50% of proceeds are donated to The Kidney Cancer Association to help individuals affected by kidney cancer.
While we expected patients would prefer one drug over the other, due to the known side effects, we didnt expect this great a preference, said the studys lead author, Bernard J. Escudier, M.D.
Recorded live at M. D. Anderson Cancer Center, Houston, Texas, these videos feature world-renown experts in the treatment of renal cancers.
Although the research is still in its trial stage, researchers have found that lactoferrin is effective against some forms of lung and kidney cancer.
The Obama administration had previously denied the existence of a deal involving political support.
The world's largest kidney cancer charity, Chicago-based Kidney Cancer Association (KCA), will distribute its newest publication for patients and their families, June 2, 2012, at the American Society of Clinical Oncology (ASCO) Annual Meeting. 'We Have Kidney Cancer: Survivors Stories ,' offers hope and inspiration to those newly-diagnosed with renal cancers, through a series of interviews with people who have lived for many years with the disease.
|Powered by NeonCRM|